by Arun Apte, CEO, CloudLIMS.com
The unstoppable surge of the regulated cannabis industry in the United States has been nothing short of phenomenal. With the legalization of cannabis in different states, this budding industry is expected to bloom and reach a staggering $82.3 billion by 2027. One of the key drivers of this explosive growth is the gradual but undeniable shift towards the acceptance and legalization of cannabis for both medicinal and recreational use. As of April 24, 2023, medical cannabis has been granted legal recognition in 38 states, three territories, and the District of Columbia. Additionally, laws allowing the recreational use of cannabis have been passed in 22 states. This trend is set to continue, as more states recognize the potential benefits of legalizing cannabis, such as generating more tax revenue, creating job opportunities, and providing medical relief.
The legalization of cannabis has also spurred innovation in the industry, leading to new research and development, and a plethora of new cannabis products such as edibles, oils, and tinctures in the market. The demand for these products is driving the industry's growth, creating new opportunities for entrepreneurs and investors. From cannabis growers to processors, testing laboratories, and distributors, the industry is witnessing a flurry of new enterprises providing legal, financial, and consulting services.
However, with success comes challenges. One such obstacle is THC inflation, which gained attention in 2022. This problem has led to widespread laboratory shopping as growers strive to produce and sell products with the highest levels of THC. The industry must address this to maintain its momentum and ensure responsible and sustainable growth.
Read more on Labcompare